Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Gardol
2. Lauroyl Sarcosine
3. N-dodecanoyl-n-methylglycine
4. N-lauroyl Sarcosinate
5. N-lauroyl Sarcosine
6. N-lauroyl-n-methylaminoacetic Acid
7. N-lauroylsarcosinate
8. N-lauroylsarcosine Sodium Salt
9. N-methyl-n-(1-oxododecyl)glycine Sodium Salt (1:1)
10. Sarcosyl Nl
11. Sarkosyl
12. Sarkosyl L
13. Sarkosyl Nl
14. Sarkosyl Nl 30
15. Sarkosyl, Ammonium Salt
16. Sarkosyl, Potassium Salt
17. Sodium Lauroyl Sarcosinate
18. Sodium N-lauroyl Sarcosinate
19. Sodium N-lauroylsarcosinate
20. Sodium N-laurylsarcosinate
1. 97-78-9
2. Lauroyl Sarcosine
3. Glycine, N-methyl-n-(1-oxododecyl)-
4. Lauroylsarcosine
5. N-dodecanoyl-n-methylglycine
6. N-dodecanoylsarcosine
7. Hamposyl L
8. N-laurylsarcosine
9. N-lauroyl Sarcosinate
10. Maprosyl L
11. Sarcosyl L
12. Sarkosyl L
13. 2-[dodecanoyl(methyl)amino]acetic Acid
14. Sarkosyl
15. N-lauroyl-n-methylaminoacetic Acid
16. Sarcosine, N-lauroyl-
17. Crodasinic L
18. 2-(n-methyldodecanamido)acetic Acid
19. Nikkol Sarcosinate Lh
20. Nsc 96994
21. Lij19p3l6f
22. Nsc-96994
23. Unii-lij19p3l6f
24. Vanseal Ls
25. Einecs 202-608-3
26. Mfcd00021749
27. Lowenol L Acid
28. Ec 202-608-3
29. Dsstox_cid_22011
30. Dsstox_rid_79902
31. Dsstox_gsid_42011
32. Schembl61098
33. Lauroyl Sarcosine [ii]
34. Chembl1907464
35. Dtxsid7042011
36. Lauroyl Sarcosine [inci]
37. Chebi:183705
38. N-methyl-n-(1-oxododecyl)glycine
39. N-lauroylsarcosine, Neat, >=95%
40. Nsc96994
41. N-methyl-n-(1-oxododecyl) Glycine
42. Tox21_301352
43. Stl452997
44. Zinc38141468
45. Glycine,n-methyl-n-(1-oxododecyl)-
46. Akos009158126
47. [dodecanoyl(methyl)amino]acetic Acid #
48. Hy-w141881
49. Cas-97-78-9
50. Ncgc00255839-01
51. Ls-14453
52. Cs-0201675
53. L0151
54. D78483
55. N-lauroylsarcosine, Purum P.a., >=98.0% (gc)
56. W-109367
57. Q27283002
Molecular Weight | 271.40 g/mol |
---|---|
Molecular Formula | C15H29NO3 |
XLogP3 | 4.5 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 12 |
Exact Mass | 271.21474379 g/mol |
Monoisotopic Mass | 271.21474379 g/mol |
Topological Polar Surface Area | 57.6 Ų |
Heavy Atom Count | 19 |
Formal Charge | 0 |
Complexity | 254 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Detergents
Purifying or cleansing agents, usually salts of long-chain aliphatic bases or acids, that exert cleansing (oil-dissolving) and antimicrobial effects through a surface action that depends on possessing both hydrophilic and hydrophobic properties. (See all compounds classified as Detergents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
A N-Lauroylsarcosine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of N-Lauroylsarcosine, including repackagers and relabelers. The FDA regulates N-Lauroylsarcosine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. N-Lauroylsarcosine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A N-Lauroylsarcosine supplier is an individual or a company that provides N-Lauroylsarcosine active pharmaceutical ingredient (API) or N-Lauroylsarcosine finished formulations upon request. The N-Lauroylsarcosine suppliers may include N-Lauroylsarcosine API manufacturers, exporters, distributors and traders.
click here to find a list of N-Lauroylsarcosine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A N-Lauroylsarcosine DMF (Drug Master File) is a document detailing the whole manufacturing process of N-Lauroylsarcosine active pharmaceutical ingredient (API) in detail. Different forms of N-Lauroylsarcosine DMFs exist exist since differing nations have different regulations, such as N-Lauroylsarcosine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A N-Lauroylsarcosine DMF submitted to regulatory agencies in the US is known as a USDMF. N-Lauroylsarcosine USDMF includes data on N-Lauroylsarcosine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The N-Lauroylsarcosine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of N-Lauroylsarcosine suppliers with USDMF on PharmaCompass.
N-Lauroylsarcosine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of N-Lauroylsarcosine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right N-Lauroylsarcosine GMP manufacturer or N-Lauroylsarcosine GMP API supplier for your needs.
A N-Lauroylsarcosine CoA (Certificate of Analysis) is a formal document that attests to N-Lauroylsarcosine's compliance with N-Lauroylsarcosine specifications and serves as a tool for batch-level quality control.
N-Lauroylsarcosine CoA mostly includes findings from lab analyses of a specific batch. For each N-Lauroylsarcosine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
N-Lauroylsarcosine may be tested according to a variety of international standards, such as European Pharmacopoeia (N-Lauroylsarcosine EP), N-Lauroylsarcosine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (N-Lauroylsarcosine USP).
LOOKING FOR A SUPPLIER?